Literature DB >> 6028466

Late changes in peripheral blood after thorotrast administration.

A O Langlands, E R Williamson.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 6028466      PMCID: PMC1842531          DOI: 10.1136/bmj.3.5559.206

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis.

Authors:  M C BRAIN; J V DACIE; D O HOURIHANE
Journal:  Br J Haematol       Date:  1962-10       Impact factor: 6.998

2.  MALIGNANCY AND OTHER LATE EFFECTS FOLLOWING ADMINISTRATION OF THOROTRAST.

Authors:  J S DA HORTA; L C DA MOTTA; J D ABBATT; M L RORIZ
Journal:  Lancet       Date:  1965-07-31       Impact factor: 79.321

3.  The significance of Howell-Jolly bodies and giant metamyelocytes in marrow smears.

Authors:  D W DAWSON; H P BURY
Journal:  J Clin Pathol       Date:  1961-07       Impact factor: 3.411

4.  Considerations of the limits of radiation dosage from thorotrast.

Authors:  J RUNDO
Journal:  Br J Radiol       Date:  1955-11       Impact factor: 3.039

5.  The diagnostic significance of burr red blood cells.

Authors:  S O SCHWARTZ; S A MOTTO
Journal:  Am J Med Sci       Date:  1949-11       Impact factor: 2.378

6.  Howell-Jolly bodies in idiopathic steatorrhoea.

Authors:  I D Fraser; C F McCarthy; A E Read
Journal:  J Clin Pathol       Date:  1966-03       Impact factor: 3.411

  6 in total
  8 in total

1.  A case of acute lymphoblastic leukemia and thorotrast-accumulation.

Authors:  M A Gobets; H Nowotny; F Ruzicka; H Hanak; A Stacher
Journal:  Blut       Date:  1975-07

2.  Cholagiocarcinoma in a patient previously given thorotrast.

Authors:  P K Johnson; R R Babb
Journal:  Am J Dig Dis       Date:  1975-04

3.  [Clinical, histological and cytogenetic findings in patients with thorotrast lesions].

Authors:  H H Hennekeuser; P Citoler; H Niemczyk; A Gropp
Journal:  Klin Wochenschr       Date:  1970-08-01

4.  Long-term hazards of Thorotrast.

Authors:  J T Boyd; A O Langlands; J J Maccabe
Journal:  Br Med J       Date:  1968-06-01

5.  Thorotrast administration followed by myelofibrosis.

Authors:  A G Arnold; M H Oelbaum
Journal:  Postgrad Med J       Date:  1980-02       Impact factor: 2.401

6.  Haemangioendothelioma (Kupffer cell angiosarcoma), myelofibrosis, splenic atrophy, and myeloma paraproteinaemia after parenteral thorotrast administration.

Authors:  R C Jennings; S E Priestley
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

7.  Thyroid disease following the administration of thorotrast.

Authors:  A O Langlands; K Hermann
Journal:  J Clin Pathol       Date:  1967-11       Impact factor: 3.411

8.  Angiosarcoma of the liver: a marker tumour for the late effects of Thorotrast in Great Britain.

Authors:  P J Baxter; A O Langlands; P P Anthony; R N Macsween; P J Scheuer
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.